R&G PharmaStudies Co., Ltd. announced on 25 April 2023 the profit distribution proposal for 2022 as follows: Cash dividend/10 shares (tax included): CNY 2.50000000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
44.58 CNY | +0.61% | -3.04% | -30.86% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-30.86% | 591M | |
+17.73% | 83.46B | |
-32.08% | 67.33B | |
-2.25% | 25.66B | |
+3.03% | 17.91B | |
-13.68% | 16.54B | |
+0.75% | 15.43B | |
+74.92% | 13.46B | |
+73.16% | 12.78B | |
-2.02% | 12.33B |
- Stock Market
- Equities
- 301333 Stock
- News R&G PharmaStudies Co., Ltd.
- R&G Pharmastudies Co., Ltd. Proposes Cash Final Dividend for 2022